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experimental explants. To overcome the embryonic lethality of both
β-catenin and Eomesodermin mutant embryos, we crossed mice with
conditional (floxed) β-catenin stabilized, β-catenin null and Eome-
sodermin null alleles, with the inducible Cre-driver mouse line,
Claudin-6CreERT2 which is specific to the endodermal compartment.
Also, by tuning the tamoxifen dosage, mosaic recombination will be
enabled by the CreERT2 system, and used for clonal studies. At
present, we are conducting an exhaustive phenotypical analysis in
conjunction with biochemical studies and the establishment of in
vitro organoid cultures from mutant and control mice. Disclosing the
transcription factor networks involved in endoderm and intestinal
progenitor specification is absolutely critical to a better under-
standing of the ontogeny of various gut diseases, and will encourage
the development of novel therapeutics, considerably improving
human health.
doi:10.1016/j.ydbio.2011.05.237
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In type-1 diabetic patients glucose homeostasis is regulated by
frequent injections of insulin. Beta cell mass can be restored by islet
transplantation, but lack of organ donors and the requirement for
immunosuppressants make this approach problematic. Recent develop-
ments in protocols to differentiate embryonic stem cells to beta cells
provide hope for a renewable source of transplantable beta cells. In
vertebrates Pdx1-expressing endoderm cells give rise to endocrine and
exocrine cell lineages. Inpreviousworkwe established that development
of all pancreatic lineages requires retinoic acid (RA) signalingupstreamof
Pdx1. However, the gene regulatory network that leads to endocrine
pancreas specification downstream of RA signaling is not well character-
ized. Using an unbiased microarray approach we identified Mnx1 (Hb9)
as a RA regulated endoderm transcription factor. By combining
manipulation of gene function with transgenic reporter analysis we
establish a critical role for Mnx1 in controlling cell fate decisions within
the endocrine pancreas progenitor lineage. Previous studies in both
zebrafish and mouse have revealed that Mnx1 plays a role in beta cell
development. Here, we show that RA signaling regulates the expression
of mnx1 in the endoderm, and that mnx1 functions downstream of RA
signaling to establish beta cell fate. Published work has shown that
morpholino-mediated knock downof zebrafishmnx1 decreases beta cell
number. We now demonstrate that in Mnx1-deficient embryos beta cell
precursors fail to express insulin and convert to glucagon expressing
alpha cells. In summary, we propose thatmnx1 functions downstream of
RA signaling in the endocrine progenitors to promote beta cell fate.
doi:10.1016/j.ydbio.2011.05.238
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Maturity onset diabetes of the young 5 (MODY5) is a monogenic
form of juvenile diabetes caused by heterozygous mutations in the
gene encoding the transcription factor HNF1B (Hepatic Nuclear Factor
1B). While MODY5 patients commonly present with a hypoplastic
pancreas, it remains unclear how mutations in HNF1B affect
developmental of the pancreas or cause diabetes. Currently, only
animals with extreme loss of function Hnf1b alleles have been
studied, but these models exhibit severe endoderm regionalization
defects that preclude analysis of pancreas development and function.
We have now identified a novel zebrafish mutant with a partial loss
of function mutation in hnf1b that phenocopies MODY5 pancreatic
defects. Using this novel hnf1b mutant, we have uncovered a
synthetic genetic interaction with Wnt/β-Catenin signaling in
specifying hepatopancreatic progenitors. We are using gain and loss
of function experiments to determine the mechanism of their genetic
interaction. Our studies suggest that Hnf1b is necessary for Wnt/β-
Catenin activity to induce hepatopancreatic development in the
endoderm. This work has profound implications for diabetes etiology
and may provide insight into the molecular events necessary for in
vitro generation of therapeutic pancreas and liver cells.
doi:10.1016/j.ydbio.2011.05.239
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There have been increasing efforts to generate insulin-producing
beta-cells in culture for therapeutic uses, drawing on the biological
concepts learned from developmental biology. However, these cultures
have yet to reproducibly produce glucose-responsive, mature beta-cells,
indicating that a greater understanding of the developmental processes
to generate fully functional beta-cells is needed. Grg3 (Groucho Related
Gene 3) is a member of the Groucho/TLE family of corepressors which
facilitates repression of gene expression, and its function in various cell
contexts are mediated by its recruitment to target genes by different
transcription factors. Grgs broadly regulate the progression of progeni-
tor cells to differentiated cell types and direct cell fate decisions during
development. We have found that Grg3 is expressed in most beta-cells
and a subset of other endocrine cell types in the fetal and adult mouse
pancreas. We have also determined by Ngn3-Cre driven cell lineage
tracing experiments that Grg3 is activated in Ngn3+ endocrine
progenitor descendants just after transient Ngn3 expression. Analysis
of Grg3 knockout embryos determined that a smaller but morphologi-
cally normal pancreas (including primary transition glucagon cells) is
formed by E13.5. However, the bulk of endocrine differentiation known
as the secondary transition occurs around E14, but the vast majority of
Grg3 knockout embryos die before E14.5 because of placental defects.
Therefore, we explanted E12.5 pancreata to allow differentiation to
occur in culture. While control explants displayed all aspects of
pancreatic differentiation including exocrine (amylase), ductal (muc1)
and endocrine (insulin, glucagon) differentiation, Grg3 knockout
explants displayed a drastic decrease (~85% decrease) in endocrine cell
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differentiation. This data indicates that Grg3 is required for the initial
differentiation of secondary transition endocrine cells after the Ngn3
endocrine commitment step. Future experiments will determine the
direct gene targets of Grg3 and the transcription factors that recruit Grg3
in the pro-endocrine context.
doi:10.1016/j.ydbio.2011.05.240
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